APEX Ventures

Quibim, headquartered in Valencia, Spain, is a leader in whole-body medical imaging analysis, providing innovative AI-based image processing technologies. Its products, utilized by pharmaceutical companies and research teams globally, focus on extracting quantitative information from radiological images. Quibim Precision®, the company's whole-body imaging ecosystem, supports a variety of applications, from disease detection to monitoring the effectiveness of new treatments. By employing an AI-first approach, Quibim enables partners to accurately identify pathologies across different body parts and imaging modalities, ultimately enhancing the diagnosis of high-incidence illnesses and assessing treatment outcomes. This commitment to leveraging advanced imaging biomarkers contributes significantly to improving human health.

Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.

HyperHeat is developing an innovative all-electric heating solution capable of achieving temperatures up to 2,000°C, utilizing renewable electricity to provide an efficient alternative to fossil fuel combustion. With an impressive efficiency rate of up to 98%, HyperHeat's technology is particularly suited for retrofitting industrial processes, facilitating significant reductions in CO2 emissions across sectors such as steel, cement, and chemicals. The scalable nature of the technology offers a cost-effective means to decarbonize thermal processes, with the potential to lower global CO2 emissions by over 4.5 gigatons annually. Currently operating in stealth mode, HyperHeat aims to support energy-intensive industries in their transition to zero carbon emissions, addressing the urgent challenge of climate change.

Founded as a spin-off from Ruhr-University Bochum in Germany, GEMESYS is pioneering next-generation AI chips with cutting-edge technology built on memristors—novel electronic components that enable highly efficient neural network processing. Designed for on-device training and inference, GEMESYS' technology unlocks a range of new use cases for Edge AI.

TriLite Technologies GmbH, based in Vienna, Austria, specializes in the manufacturing and sale of ultra-small RGB laser beam scanners. These advanced devices are designed for use in augmented reality (AR), mixed reality (MR), and virtual reality (VR) head-mounted displays, as well as in head-up displays and various projection applications, including Pico and smart home technologies. TriLite employs innovative machine learning algorithms and proprietary multi-parameter software to enhance the performance of its laser beam scanning solutions, achieving remarkable advancements in size, weight, and image quality. The company's software-first architecture underpins its cutting-edge technology, positioning TriLite as a leader in the field of compact projection displays.

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

Senisca is a senotherapeutics company established in 2020, focused on developing anti-aging oligonucleotide therapeutics. The company aims to provide innovative pharmaceutical treatments for age-related chronic diseases by creating a new generation of oligonucleotide-based interventions. These therapeutics target the underlying mechanisms of aging, restoring the ability of cells to regulate gene expression effectively. By rejuvenating aged cells, Senisca seeks to improve healthspan and address both the diseases and aesthetic manifestations of aging, ultimately enabling individuals to live healthier for longer periods.

Zetta Genomics is a Cambridge-based company established in 2018 that focuses on managing large-scale genomic data to advance precision medicine. The company operates a user-centric platform that facilitates connections between individuals and researchers, allowing users to opt in or out of studies related to various health conditions, including common disorders like eczema and diabetes, as well as rare diseases such as muscular dystrophy. By employing distributed database technology and robust security measures, Zetta Genomics ensures the privacy of genomic data while enabling scientists to access dynamic health and genetic datasets for personalized medicine research. The platform emphasizes transparency and control for users throughout the data-sharing process.

Solvemed Limited stands at the forefront of innovation in neurological care, leveraging advanced AI technology to pioneer precision diagnostics and personalized treatment recommendations. Our cutting-edge solutions empower healthcare professionals with unprecedented insights, enabling early detection and monitoring of neurological disorders such as Parkinson's disease. With a steadfast commitment to improving patient outcomes, we seamlessly integrate our AI-driven platform to revolutionize the landscape of neurology diagnostics and drug discovery. Backed by a dedicated team of experts and powered by state-of-the-art technology, Solvemed Limited remains steadfast in its mission to redefine the standards of neurological care worldwide.

sewts GmbH, founded in 2019 and located in Munich, Germany, specializes in automation technology focused on the processing of easily deformable materials, particularly textiles. The company collaborates with the Technical University of Munich to create finite element (FE) simulations that accurately replicate textile behavior. Its flagship product, Velum, is an AI-driven technology that analyzes textiles and converts insights into robotic commands. This innovative solution supports real-time motion and trajectory planning, enabling efficient control of industrial robots and coordination among multiple robots. sewts' technology streamlines complex manual processes in industrial settings, such as laundries and garment manufacturing, while promoting sustainability and innovation in production methods. The company is supported by several investors, including APEX Ventures and Bayern Kapital, which underscores its commitment to advancing the robotics and textile industries.

Upfront Diagnostics specializes in the development of innovative blood biomarkers aimed at improving the diagnosis of stroke patients, particularly those suffering from large vessel occlusions. By facilitating rapid and accurate identification of this stroke subtype, the company's biomarkers enable healthcare professionals, including clinicians, paramedics, and nurses, to deliver timely treatment. This advancement is expected to reduce the time to intervention, ultimately decreasing the likelihood of disabilities and fatalities associated with strokes. Upfront Diagnostics holds a portfolio of patents that protect its proprietary biomarkers, underscoring its commitment to enhancing patient care through more effective diagnostic tools.

Zetta Genomics is a Cambridge-based company established in 2018 that focuses on managing large-scale genomic data to advance precision medicine. The company operates a user-centric platform that facilitates connections between individuals and researchers, allowing users to opt in or out of studies related to various health conditions, including common disorders like eczema and diabetes, as well as rare diseases such as muscular dystrophy. By employing distributed database technology and robust security measures, Zetta Genomics ensures the privacy of genomic data while enabling scientists to access dynamic health and genetic datasets for personalized medicine research. The platform emphasizes transparency and control for users throughout the data-sharing process.

Planqc is a developer of advanced quantum computing technology that focuses on achieving useful quantum advantage by leveraging individual atoms as qubits, the fundamental units of quantum information. The company’s quantum computers process information by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. This innovative approach allows Planqc to efficiently scale its technology to thousands of qubits, making it well-positioned to meet the demands of various industries seeking to harness the power of quantum computing. Through its unique combination of quantum technologies, Planqc aims to lead in delivering practical solutions that utilize quantum information stored in atomic qubits.

Refined Laser Systems is a biophotonics company that develops advanced laser systems for applications in stimulated Raman scattering (SRS) microscopy and quantum technology. The company focuses on manufacturing innovative devices designed for stain-free tissue diagnostics, allowing for quick and reliable results within minutes. Utilizing fiber-based tunable picosecond laser technology, Refined Laser Systems offers devices that feature fast switching speeds and robust performance, which enhances automation in laboratory settings. This technology enables researchers to significantly reduce the time needed for accurate diagnostics, thereby improving efficiency in scientific and medical research.

OroraTech is a global intelligence-as-a-service company focused on leveraging thermal data to promote sustainability. Established in 2018 and headquartered in Munich, Germany, with operations in Canada and Brazil, OroraTech has developed a comprehensive monitoring network that provides real-time situational awareness and risk alerts for wildfire detection. Their flagship product, the Wildfire Solution, utilizes high-resolution thermal data from a proprietary nanosatellite constellation and public space-based sensors, allowing for the detection of fires of any scale at any time. This innovative technology enables clients to access reliable data and first-in-class algorithms for effective wildfire detection and severe weather forecasting. With a team of over 100 experts, OroraTech is dedicated to providing advanced solutions that contribute to a sustainable future.

Solvemed Group focuses on improving neurological care, particularly in the realm of neurodegenerative diseases such as Parkinson's disease. The company utilizes proprietary machine learning technology to create innovative diagnostic-predictive digital biomarkers, which facilitate accurate and early diagnosis and monitoring for patients. By addressing the significant shortcomings in current diagnostic standards, Solvemed aims to enhance treatment outcomes and optimize healthcare systems. Their work not only assists in providing reliable diagnostics but also plays a crucial role in revolutionizing drug discovery, enabling the development of disease-modifying therapies. Collaborating with leading research institutions, Solvemed's team of scientists and technology experts strives to advance clinical trial efficiency and ultimately improve quality of care for neurological patients.

Lyfegen is an independent provider of drug access, pricing, and rebate management solutions, with operations in Basel, Switzerland, and Boston, USA. The company specializes in helping healthcare payers and pharmaceutical companies establish appropriate pricing agreements for medications while efficiently managing drug rebates. Its platform is designed for the healthcare industry, assisting health insurance providers, pharmaceutical companies, MedTech firms, and hospitals worldwide in collecting, analyzing, and reconciling diverse healthcare data. This technology facilitates the automation of value-based healthcare contracting, ultimately aiming to enhance access to treatments, improve patient health outcomes, and increase affordability.

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

OKAPI:Orbits is a software-as-a-service startup focused on enhancing the sustainability of space travel through advanced collision avoidance solutions for satellites. The company provides a comprehensive platform that includes features such as environmental visualization, maneuver design, conjunction analysis, re-entry predictions, and high-accuracy orbit propagation. These tools enable researchers and satellite operators to effectively monitor risks and ensure secure operations in space, contributing to a more sustainable environment in orbit. By facilitating seamless integration with ground segments, OKAPI:Orbits aims to support the growing demands of space exploration while prioritizing safety and sustainability.

Senisca is a senotherapeutics company established in 2020, focused on developing anti-aging oligonucleotide therapeutics. The company aims to provide innovative pharmaceutical treatments for age-related chronic diseases by creating a new generation of oligonucleotide-based interventions. These therapeutics target the underlying mechanisms of aging, restoring the ability of cells to regulate gene expression effectively. By rejuvenating aged cells, Senisca seeks to improve healthspan and address both the diseases and aesthetic manifestations of aging, ultimately enabling individuals to live healthier for longer periods.

Elucidate GmbH, founded in 2019 and based in Berlin, Germany, specializes in financial crime risk management through its innovative platform, the Elucidate FinCrime Index (EFI). This platform employs probabilistic modeling and machine learning to assess and quantify financial crime risks for financial institutions. By providing comprehensive data analysis, the EFI enables clients to measure, assess, and standardize their financial crime risks, allowing them to define acceptable risk exposure levels and monitor these continuously. Additionally, Elucidate's ratings and risk pricing products facilitate collaborative efforts between front and back office teams, enhancing customer service and promoting lawful behavior within the financial sector.

Celeris Therapeutics is an AI-driven drug discovery company focused on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address diseases with significant unmet medical needs, including Parkinson's disease and various cancers. The company utilizes its proprietary Celeris One platform, which employs structure-based geometric deep learning to enhance the design and development of degraders. This platform aids in the prioritization of specific E3 ligases, the design of linkers, and the selection of the most promising compounds for synthesis. Additionally, Celeris Therapeutics operates an automated laboratory that rapidly generates experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to co-develop small-molecule degrader therapies across various therapeutic areas while also building its own drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

Zetta Genomics is a Cambridge-based company established in 2018 that focuses on managing large-scale genomic data to advance precision medicine. The company operates a user-centric platform that facilitates connections between individuals and researchers, allowing users to opt in or out of studies related to various health conditions, including common disorders like eczema and diabetes, as well as rare diseases such as muscular dystrophy. By employing distributed database technology and robust security measures, Zetta Genomics ensures the privacy of genomic data while enabling scientists to access dynamic health and genetic datasets for personalized medicine research. The platform emphasizes transparency and control for users throughout the data-sharing process.

Morpher operates a blockchain trading platform that enables users to trade stocks, commodities, and currencies without incurring fees and with infinite liquidity. Utilizing Virtual Futures on the Ethereum blockchain, the platform allows users to stake its native token on the price movements of various markets. The protocol serves as the counterparty, minting or burning tokens in response to price changes. By eliminating traditional intermediaries such as banks and brokers, Morpher facilitates a seamless trading experience available 24/7. Users can short markets, trade with leverage, and even create new markets for emerging assets. This innovative approach aims to democratize trading on a global scale.

Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the manufacture of innovative refrigeration solutions, particularly magnetic cooling technology that provides cryogen-free cooling services. The company offers turn-key cryostats designed for research and industrial clients, facilitating low-temperature investigations of material samples and enhancing the development of quantum hardware and related electronics. Kiutra's cooling platforms achieve continuous sub-Kelvin temperatures without reliance on rare and costly helium-3, which simplifies the provision of cryogenic environments in a compact and cost-effective manner. This technology is crucial for various applications in quantum computing, quantum communications, and quantum sensing, enabling advancements in scalable quantum technologies.

TriLite Technologies GmbH, based in Vienna, Austria, specializes in the manufacturing and sale of ultra-small RGB laser beam scanners. These advanced devices are designed for use in augmented reality (AR), mixed reality (MR), and virtual reality (VR) head-mounted displays, as well as in head-up displays and various projection applications, including Pico and smart home technologies. TriLite employs innovative machine learning algorithms and proprietary multi-parameter software to enhance the performance of its laser beam scanning solutions, achieving remarkable advancements in size, weight, and image quality. The company's software-first architecture underpins its cutting-edge technology, positioning TriLite as a leader in the field of compact projection displays.

contextflow GmbH is a company based in Vienna, Austria, specializing in machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, it has developed a 3D image-based search engine that enables radiologists to quickly identify regions of interest in medical images, particularly in lung CT scans. This technology allows for the rapid retrieval of similar cases and relevant clinical information, enhancing decision-making processes in diagnostics. contextflow's software is designed to integrate seamlessly with existing radiology workflows, thereby improving efficiency and patient care. The company has established strategic partnerships with various organizations, including radiology centers and health associations, and is currently conducting trials of its software with multiple partners. Recognized for its innovation, contextflow has received several awards and was selected to participate in an accelerator program aimed at advancing health technology.

Mobius Labs GmbH, founded in 2018 and based in Berlin, Germany, specializes in developing advanced image and video understanding software. The company offers a range of lightweight computer vision algorithms that are licensed for use across various applications, devices, and processes. Its flagship product, Superhuman Vision, utilizes few-shot learning models that can be easily integrated into existing systems and customized by non-experts. This technology allows for the creation of new models that can operate on edge devices with limited processing capabilities. By transforming images and videos into insightful metadata, Mobius Labs enables businesses to enhance visual searches and gain a competitive advantage in markets reliant on visual content analysis.

Celeris Therapeutics is an AI-driven drug discovery company focused on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address diseases with significant unmet medical needs, including Parkinson's disease and various cancers. The company utilizes its proprietary Celeris One platform, which employs structure-based geometric deep learning to enhance the design and development of degraders. This platform aids in the prioritization of specific E3 ligases, the design of linkers, and the selection of the most promising compounds for synthesis. Additionally, Celeris Therapeutics operates an automated laboratory that rapidly generates experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to co-develop small-molecule degrader therapies across various therapeutic areas while also building its own drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

VividQ Limited is a software company specializing in the development of a framework that enables the generation, compression, and transmission of 3D holographic images and video. The company offers several key products, including VividQ Capture, which standardizes 3D data for holographic display, and VividQ Squeeze, a compression solution for point cloud data storage. Additionally, VividQ Core facilitates multi-user interactions with holograms, while VividQ View allows developers to integrate various spatial light modulators into their systems. The company's technology is utilized across various sectors, including consumer electronics, augmented and virtual reality, automotive displays, and immersive simulations. Founded in 2015 and based in Cambridge, United Kingdom, VividQ collaborates with leading original equipment manufacturers to integrate its advanced software and hardware solutions into next-generation consumer devices, aiming to create a seamless blend of real and virtual experiences.

Yuri specializes in designing and manufacturing hardware for the aviation and aerospace industry, focusing on applications in microgravity research and experiments. The company provides an end-to-end space mission platform that includes services such as mission definition, hardware selection and development, as well as launch and return logistics. Additionally, Yuri supports researchers with a variety of advanced scientific services, including 3D cell culture growth, human disease modeling, protein and molecule analysis, synthetic biology, plant biology studies, and nanofluidics. This comprehensive approach enables researchers to access a quick and cost-effective combination of experimental hardware, facilities, and microgravity platforms.

OroraTech is a global intelligence-as-a-service company focused on leveraging thermal data to promote sustainability. Established in 2018 and headquartered in Munich, Germany, with operations in Canada and Brazil, OroraTech has developed a comprehensive monitoring network that provides real-time situational awareness and risk alerts for wildfire detection. Their flagship product, the Wildfire Solution, utilizes high-resolution thermal data from a proprietary nanosatellite constellation and public space-based sensors, allowing for the detection of fires of any scale at any time. This innovative technology enables clients to access reliable data and first-in-class algorithms for effective wildfire detection and severe weather forecasting. With a team of over 100 experts, OroraTech is dedicated to providing advanced solutions that contribute to a sustainable future.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced liquid-crystal display (LCD) backlighting solutions. The company utilizes glass-based waveguides and laser-powered photonic integrated circuits to create a groundbreaking quantum light chip that enhances display technology. This innovation replaces traditional backlight units with dedicated light sources for each sub-pixel, significantly improving energy efficiency, brightness, contrast ratio, and color rendering. VitreaLab's technology is designed to deliver high-quality illumination for 3D, virtual reality (VR), and augmented reality (AR) applications, offering unparalleled brightness and color quality while consuming less energy than competing solutions.

contextflow GmbH is a company based in Vienna, Austria, specializing in machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, it has developed a 3D image-based search engine that enables radiologists to quickly identify regions of interest in medical images, particularly in lung CT scans. This technology allows for the rapid retrieval of similar cases and relevant clinical information, enhancing decision-making processes in diagnostics. contextflow's software is designed to integrate seamlessly with existing radiology workflows, thereby improving efficiency and patient care. The company has established strategic partnerships with various organizations, including radiology centers and health associations, and is currently conducting trials of its software with multiple partners. Recognized for its innovation, contextflow has received several awards and was selected to participate in an accelerator program aimed at advancing health technology.

sewts GmbH, founded in 2019 and located in Munich, Germany, specializes in automation technology focused on the processing of easily deformable materials, particularly textiles. The company collaborates with the Technical University of Munich to create finite element (FE) simulations that accurately replicate textile behavior. Its flagship product, Velum, is an AI-driven technology that analyzes textiles and converts insights into robotic commands. This innovative solution supports real-time motion and trajectory planning, enabling efficient control of industrial robots and coordination among multiple robots. sewts' technology streamlines complex manual processes in industrial settings, such as laundries and garment manufacturing, while promoting sustainability and innovation in production methods. The company is supported by several investors, including APEX Ventures and Bayern Kapital, which underscores its commitment to advancing the robotics and textile industries.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.

Elucidate GmbH, founded in 2019 and based in Berlin, Germany, specializes in financial crime risk management through its innovative platform, the Elucidate FinCrime Index (EFI). This platform employs probabilistic modeling and machine learning to assess and quantify financial crime risks for financial institutions. By providing comprehensive data analysis, the EFI enables clients to measure, assess, and standardize their financial crime risks, allowing them to define acceptable risk exposure levels and monitor these continuously. Additionally, Elucidate's ratings and risk pricing products facilitate collaborative efforts between front and back office teams, enhancing customer service and promoting lawful behavior within the financial sector.

Phantasma Labs Limited, founded in 2018 and based in London, specializes in developing a simulation platform that creates essential data sets and models of human behavior to train autonomous vehicles. The company focuses on enhancing self-driving cars' understanding of human interactions by placing real individuals in virtual environments, allowing artificial intelligence to learn from realistic scenarios. Its platform employs reinforcement learning to generate extensive data sets reflective of actual situations, modeling the behavior of pedestrians, cyclists, and other road users. This approach enables clients to gain insights from real-life interactions without the risks associated with actual accidents, thereby improving the decision-making capabilities of autonomous systems in extreme circumstances.

Morpher operates a blockchain trading platform that enables users to trade stocks, commodities, and currencies without incurring fees and with infinite liquidity. Utilizing Virtual Futures on the Ethereum blockchain, the platform allows users to stake its native token on the price movements of various markets. The protocol serves as the counterparty, minting or burning tokens in response to price changes. By eliminating traditional intermediaries such as banks and brokers, Morpher facilitates a seamless trading experience available 24/7. Users can short markets, trade with leverage, and even create new markets for emerging assets. This innovative approach aims to democratize trading on a global scale.

Novoic Ltd is a digital biotech company based in London, United Kingdom, that specializes in AI-driven speech analytics to assist clinicians in diagnosing neurological diseases. Established in 2019, Novoic has developed a comprehensive platform that includes proprietary technologies such as Sforza, which features libraries for audio and language feature extraction. The platform employs advanced machine learning algorithms and leverages a large proprietary dataset to detect early signs of dementia and other brain diseases by monitoring subtle changes in speech patterns. This innovative approach enables healthcare professionals to identify and track the progression of neurological conditions effectively.

Quibim, headquartered in Valencia, Spain, is a leader in whole-body medical imaging analysis, providing innovative AI-based image processing technologies. Its products, utilized by pharmaceutical companies and research teams globally, focus on extracting quantitative information from radiological images. Quibim Precision®, the company's whole-body imaging ecosystem, supports a variety of applications, from disease detection to monitoring the effectiveness of new treatments. By employing an AI-first approach, Quibim enables partners to accurately identify pathologies across different body parts and imaging modalities, ultimately enhancing the diagnosis of high-incidence illnesses and assessing treatment outcomes. This commitment to leveraging advanced imaging biomarkers contributes significantly to improving human health.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.

Elucidate GmbH, founded in 2019 and based in Berlin, Germany, specializes in financial crime risk management through its innovative platform, the Elucidate FinCrime Index (EFI). This platform employs probabilistic modeling and machine learning to assess and quantify financial crime risks for financial institutions. By providing comprehensive data analysis, the EFI enables clients to measure, assess, and standardize their financial crime risks, allowing them to define acceptable risk exposure levels and monitor these continuously. Additionally, Elucidate's ratings and risk pricing products facilitate collaborative efforts between front and back office teams, enhancing customer service and promoting lawful behavior within the financial sector.

TriLite Technologies GmbH, based in Vienna, Austria, specializes in the manufacturing and sale of ultra-small RGB laser beam scanners. These advanced devices are designed for use in augmented reality (AR), mixed reality (MR), and virtual reality (VR) head-mounted displays, as well as in head-up displays and various projection applications, including Pico and smart home technologies. TriLite employs innovative machine learning algorithms and proprietary multi-parameter software to enhance the performance of its laser beam scanning solutions, achieving remarkable advancements in size, weight, and image quality. The company's software-first architecture underpins its cutting-edge technology, positioning TriLite as a leader in the field of compact projection displays.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced liquid-crystal display (LCD) backlighting solutions. The company utilizes glass-based waveguides and laser-powered photonic integrated circuits to create a groundbreaking quantum light chip that enhances display technology. This innovation replaces traditional backlight units with dedicated light sources for each sub-pixel, significantly improving energy efficiency, brightness, contrast ratio, and color rendering. VitreaLab's technology is designed to deliver high-quality illumination for 3D, virtual reality (VR), and augmented reality (AR) applications, offering unparalleled brightness and color quality while consuming less energy than competing solutions.

MindPeak GmbH, founded in 2018 and headquartered in Hamburg, Germany, specializes in developing artificial intelligence software tools aimed at enhancing cancer diagnostics. The company's flagship product, BreastAI, facilitates the quantification of breast cancer immunohistochemistry (IHC) and can be integrated into third-party software systems. By automating tasks such as cell and biomarker quantification, MindPeak's solutions improve the efficiency of pathologists, allowing them to focus on critical decision-making in cancer treatment. The company also maintains a strategic relationship with Gestalt Diagnostics, further expanding its impact in the field of diagnostic automation. Through its innovative platform, MindPeak strives to make microscopical analysis more accessible and cost-effective in clinical environments.

Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the manufacture of innovative refrigeration solutions, particularly magnetic cooling technology that provides cryogen-free cooling services. The company offers turn-key cryostats designed for research and industrial clients, facilitating low-temperature investigations of material samples and enhancing the development of quantum hardware and related electronics. Kiutra's cooling platforms achieve continuous sub-Kelvin temperatures without reliance on rare and costly helium-3, which simplifies the provision of cryogenic environments in a compact and cost-effective manner. This technology is crucial for various applications in quantum computing, quantum communications, and quantum sensing, enabling advancements in scalable quantum technologies.

Avinew, Inc. develops artificial intelligence and telematics-based software solutions specifically for the insurance industry. Founded in 2016 and headquartered in Westlake Village, California, the company focuses on providing auto insurance services tailored for autonomous and semi-autonomous vehicles. Avinew's offerings include usage-based insurance programs that leverage driving data, artificial intelligence, and machine learning to assess premium discount eligibility. By utilizing these advanced technologies, Avinew aims to enhance road safety while delivering value to vehicle drivers and fleet operators. The company was previously known as DRIAV, Inc. and rebranded to Avinew, Inc. in January 2019.

T3K-Forensics GmbH, founded in 2007 and based in Vienna, Austria, specializes in mobile forensics software and services targeted at law enforcement agencies. The company develops advanced software solutions, including its LEAP tool, which analyzes smartphone data and generates clear reports summarizing the phone's content. In addition to software, T3K-Forensics provides tailor-made analytics solutions and mobile security services for forensic units. The company also offers training programs in areas such as mobile phone extraction, smartphone forensics, and SQLite forensics, equipping law enforcement professionals with essential skills for effective data analysis. Through its innovative approach, T3K-Forensics enhances the capabilities of law enforcement authorities worldwide in managing and analyzing mobile data.

Lendflo is a peer-to-peer invoice financing marketplace that utilizes blockchain technology and machine learning to provide small and medium-sized businesses with an efficient and cost-effective financing solution. Founded in 2017 and based in London, the platform aims to simplify the invoice financing process, enabling businesses to access funds more quickly and easily. As of May 2020, Lendflo operates as a subsidiary of ABH Holdings S.A., enhancing its capabilities within the financial technology sector.

ImageBiopsy Lab (IBL) is a leading company in the development of AI-based software for image analysis in musculoskeletal radiology, orthopaedic surgery, and traumatology. The company's platform automates the reading and prioritization of low-risk, plain film musculoskeletal X-rays, which improves efficiency by reducing the time physicians spend on manual reporting. IBL aims to address various clinically relevant musculoskeletal use cases, extending its capabilities from plain film X-rays to more complex MRI and CT scans. The firm collaborates with prominent medical institutions in the US and Europe to gather extensive training data and validation resources. This collaboration supports the creation of distinct AI modules that are undergoing certification processes, enabling IBL to offer advanced solutions for the early detection of musculoskeletal diseases like arthritis and osteoporosis. With offices in Europe and the US, IBL is committed to enhancing diagnostic accuracy while ensuring affordable patient care.

Mobius Labs GmbH, founded in 2018 and based in Berlin, Germany, specializes in developing advanced image and video understanding software. The company offers a range of lightweight computer vision algorithms that are licensed for use across various applications, devices, and processes. Its flagship product, Superhuman Vision, utilizes few-shot learning models that can be easily integrated into existing systems and customized by non-experts. This technology allows for the creation of new models that can operate on edge devices with limited processing capabilities. By transforming images and videos into insightful metadata, Mobius Labs enables businesses to enhance visual searches and gain a competitive advantage in markets reliant on visual content analysis.

contextflow GmbH is a company based in Vienna, Austria, specializing in machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, it has developed a 3D image-based search engine that enables radiologists to quickly identify regions of interest in medical images, particularly in lung CT scans. This technology allows for the rapid retrieval of similar cases and relevant clinical information, enhancing decision-making processes in diagnostics. contextflow's software is designed to integrate seamlessly with existing radiology workflows, thereby improving efficiency and patient care. The company has established strategic partnerships with various organizations, including radiology centers and health associations, and is currently conducting trials of its software with multiple partners. Recognized for its innovation, contextflow has received several awards and was selected to participate in an accelerator program aimed at advancing health technology.

HAAWK, Inc. is a media services company based in Studio City, California, that focuses on managing and monetizing the copyrights of independent music, film, and television catalogs. Founded in 2017, the company specializes in rights management, copyright enforcement, and digital music distribution, with a particular emphasis on platforms like YouTube, Facebook, and Instagram. HAAWK provides a copyright management platform that enables clients to administer, distribute, and license their content effectively. The platform also monitors user-generated content to detect unauthorized uploads, allowing copyright holders to monetize these instances through advertisements. In addition, HAAWK offers micro-sync licensing services to further support its clients in monetizing their creative works.

Kivu Technologies, established in Austria in 2016, is a multidisciplinary team comprised of engineers, developers, data scientists, analysts, and security professionals dedicated to enhancing human security through innovative technology. The company specializes in providing a network analytical platform that leverages artificial intelligence and machine learning to deliver real-time data analytical services for the security industry. This platform enables clients to visualize data as interconnected networks, facilitating rapid responses to time-sensitive questions. Kivu Technologies aims to address complex challenges related to security and safety in an increasingly connected world, believing that advancements in technology are essential for creating a safer environment.